Henry Schein (NASDAQ:HSIC) Trading Down 5.4% – Time to Sell?

Henry Schein, Inc. (NASDAQ:HSIC) dropped 5.4% during mid-day trading on Tuesday . The stock traded as low as $67.46 and last traded at $68.40. Approximately 199,112 shares were traded during trading, a decline of 85% from the average daily volume of 1,332,793 shares. The stock had previously closed at $72.33.

Analysts Set New Price Targets

HSIC has been the subject of several analyst reports. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Barrington Research reiterated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday. JPMorgan Chase & Co. reduced their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Evercore ISI boosted their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $77.50.

Henry Schein Price Performance

The business has a 50-day moving average price of $70.59 and a 200 day moving average price of $69.78. The company has a market cap of $8.87 billion, a price-to-earnings ratio of 25.93, a P/E/G ratio of 2.08 and a beta of 0.87. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.06. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the business earned $1.32 EPS. The company’s revenue was up .4% on a year-over-year basis. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.14% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

Hedge funds have recently modified their holdings of the stock. UniSuper Management Pty Ltd increased its stake in shares of Henry Schein by 611.8% in the first quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock worth $1,034,000 after acquiring an additional 11,771 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its stake in shares of Henry Schein by 64.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock worth $3,138,000 after acquiring an additional 16,241 shares during the last quarter. Thompson Siegel & Walmsley LLC acquired a new position in shares of Henry Schein in the second quarter worth $46,683,000. Nordea Investment Management AB increased its stake in shares of Henry Schein by 8.9% in the first quarter. Nordea Investment Management AB now owns 9,785 shares of the company’s stock worth $744,000 after acquiring an additional 798 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock worth $1,165,425,000 after acquiring an additional 260,537 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.